The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Subscribe To Our Newsletter & Stay Updated
